Glycylglycine (Gly-Gly)

N-Glycylglycine is a derivative of Glycine, a non-essential amino acid that enhances N-methyl-D-aspartate (NMDA) receptor mediated synaptic potentials in the neocortex of rats. Glycine is also being used as adjuvant therapy for the treatment of schizophrenia. Synonyms: Gly-Gly, Diglycine,18: PN: WO2012015910 SEQID: 19 Unclaimed Sequence, 1: PN: WO2010117786 PAGE: 166 Claimed Protein, 2-(Aminoacetamido)acetic Acid, 221: PN: EP2161028 PAGE: 11 Claimed Protein, 31: PN: FR2860236 PAGE: 10 Claimed Protein, 36: PN: EP2204377 SEQID: 36 Claimed Protein, 36: PN: WO2010076654 SEQID: 36 Claimed Protein, 69: PN: US20110195077 SEQID: 14 Claimed Sequence, 6: PN: WO2013027191 SEQID: 14 Claimed Sequence, Diglycine, Diglycocoll, Gly2, Glycine Dipeptide, N-Glycylglycine, NSC 49346, alpha-Glycylglycine, CAS No: 556-50-3, Molecular Formula: C?H?N?O?, Molecular Weight: 132.12, Appearance: White crystalline powder, Purity: 98-100.5%, Melting Point: >208°C (dec), Solubility: Water (Slightly), Loss on Drying: < 0.2%, Heavy Metals (Pb): <0.001%, Other Amino Acids: Not detectable, Chloride: <0.02%, Iron: <0.003%, Arsenic: <0.0001%, Sulfate: <0.02%, Residue on Ignition: <0.1%, Storage: RT